Literature DB >> 26514202

Receptor Activity-Modifying Proteins (RAMPs): New Insights and Roles.

Debbie L Hay1, Augen A Pioszak2.   

Abstract

It is now recognized that G protein-coupled receptors (GPCRs), once considered largely independent functional units, have a far more diverse molecular architecture. Receptor activity-modifying proteins (RAMPs) provide an important example of proteins that interact with GPCRs to modify their function. RAMPs are able to act as pharmacological switches and chaperones, and they can regulate signaling and/or trafficking in a receptor-dependent manner. This review covers recent discoveries in the RAMP field and summarizes the known GPCR partners and functions of RAMPs. We also discuss the first peptide-bound structures of RAMP-GPCR complexes, which give insight into the molecular mechanisms that enable RAMPs to alter the pharmacology and signaling of GPCRs.

Entities:  

Keywords:  CGRP; CRF; GPCR; GPR30; RAMP; VIP; adrenomedullin; amylin; calcium-sensing receptor; heterodimer

Mesh:

Substances:

Year:  2015        PMID: 26514202      PMCID: PMC5559101          DOI: 10.1146/annurev-pharmtox-010715-103120

Source DB:  PubMed          Journal:  Annu Rev Pharmacol Toxicol        ISSN: 0362-1642            Impact factor:   13.820


  102 in total

1.  The third extracellular loop of the human calcitonin receptor-like receptor is crucial for the activation of adrenomedullin signalling.

Authors:  Kenji Kuwasako; Debbie L Hay; Sayaka Nagata; Tomomi Hikosaka; Kazuo Kitamura; Johji Kato
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

2.  Structure of micelle-bound adrenomedullin: a first step toward the analysis of its interactions with receptors and small molecules.

Authors:  Javier Pérez-Castells; Sonsoles Martín-Santamaría; Lidia Nieto; Ana Ramos; Alfredo Martínez; Beatriz de Pascual-Teresa; Jesús Jiménez-Barbero
Journal:  Biopolymers       Date:  2011-08-09       Impact factor: 2.505

3.  A critical role for the short intracellular C terminus in receptor activity-modifying protein function.

Authors:  Madhara Udawela; George Christopoulos; Maria Morfis; Arthur Christopoulos; Siying Ye; Nanda Tilakaratne; Patrick M Sexton
Journal:  Mol Pharmacol       Date:  2006-08-15       Impact factor: 4.436

Review 4.  Unconventional binding sites and receptors for VIP and related peptides PACAP and PHI/PHM: an update.

Authors:  Jean-Marc Muller; Colin Debaigt; Stéphanie Goursaud; Alicia Montoni; Nicolas Pineau; Annie-Claire Meunier; Thierry Janet
Journal:  Peptides       Date:  2007-04-19       Impact factor: 3.750

5.  Differential distribution of calcitonin gene-related peptide and its receptor components in the human trigeminal ganglion.

Authors:  S Eftekhari; C A Salvatore; A Calamari; S A Kane; J Tajti; L Edvinsson
Journal:  Neuroscience       Date:  2010-05-22       Impact factor: 3.590

Review 6.  Insights into the structure of class B GPCRs.

Authors:  Kaspar Hollenstein; Chris de Graaf; Andrea Bortolato; Ming-Wei Wang; Fiona H Marshall; Raymond C Stevens
Journal:  Trends Pharmacol Sci       Date:  2013-12-18       Impact factor: 14.819

7.  A receptor activity modifying protein (RAMP)2-dependent adrenomedullin receptor is a calcitonin gene-related peptide receptor when coexpressed with human RAMP1.

Authors:  N Bühlmann; K Leuthäuser; R Muff; J A Fischer; W Born
Journal:  Endocrinology       Date:  1999-06       Impact factor: 4.736

8.  From micromolar to nanomolar affinity: a systematic approach to identify the binding site of CGRP at the human calcitonin gene-related peptide 1 receptor.

Authors:  B Rist; M Entzeroth; A G Beck-Sickinger
Journal:  J Med Chem       Date:  1998-01-01       Impact factor: 7.446

9.  Receptor activity-modifying protein 1 increases baroreflex sensitivity and attenuates Angiotensin-induced hypertension.

Authors:  Rasna Sabharwal; Zhongming Zhang; Yongjun Lu; Francois M Abboud; Andrew F Russo; Mark W Chapleau
Journal:  Hypertension       Date:  2010-01-25       Impact factor: 10.190

10.  Calcitonin gene-related peptide regulates type IV hypersensitivity through dendritic cell functions.

Authors:  Norihisa Mikami; Kaori Sueda; Yusuke Ogitani; Ippei Otani; Miku Takatsuji; Yasuko Wada; Keiko Watanabe; Rintaro Yoshikawa; Satoshi Nishioka; Nagisa Hashimoto; Yayoi Miyagi; So-ichiro Fukada; Hiroshi Yamamoto; Kazutake Tsujikawa
Journal:  PLoS One       Date:  2014-01-21       Impact factor: 3.240

View more
  54 in total

Review 1.  Role of Rab GTPases in the export trafficking of G protein-coupled receptors.

Authors:  Guansong Wang; Zhe Wei; Guangyu Wu
Journal:  Small GTPases       Date:  2017-01-27

Review 2.  SPECT and PET imaging of adrenomedullin receptors: a promising strategy for studying pulmonary vascular diseases.

Authors:  Luis Michel Alonso Martinez; François Harel; Myriam Létourneau; Vincent Finnerty; Alain Fournier; Jocelyn Dupuis; Jean N DaSilva
Journal:  Am J Nucl Med Mol Imaging       Date:  2019-10-15

3.  Calcitonin and Amylin Receptor Peptide Interaction Mechanisms: INSIGHTS INTO PEPTIDE-BINDING MODES AND ALLOSTERIC MODULATION OF THE CALCITONIN RECEPTOR BY RECEPTOR ACTIVITY-MODIFYING PROTEINS.

Authors:  Sang-Min Lee; Debbie L Hay; Augen A Pioszak
Journal:  J Biol Chem       Date:  2016-02-19       Impact factor: 5.157

Review 4.  Pituitary adenylate cyclase-activating polypeptide receptors in the trigeminovascular system: implications for migraine.

Authors:  Tahlia Sundrum; Christopher S Walker
Journal:  Br J Pharmacol       Date:  2017-10-25       Impact factor: 8.739

Review 5.  Update on the pharmacology of calcitonin/CGRP family of peptides: IUPHAR Review 25.

Authors:  Debbie L Hay; Michael L Garelja; David R Poyner; Christopher S Walker
Journal:  Br J Pharmacol       Date:  2017-11-28       Impact factor: 8.739

Review 6.  Fluorescent ligands: Bringing light to emerging GPCR paradigms.

Authors:  Mark Soave; Stephen J Briddon; Stephen J Hill; Leigh A Stoddart
Journal:  Br J Pharmacol       Date:  2020-02-06       Impact factor: 8.739

7.  Identification of Small-Molecule Positive Modulators of Calcitonin-like Receptor-Based Receptors.

Authors:  Erica R Hendrikse; Lydia P Liew; Rebekah L Bower; Muriel Bonnet; Muhammad A Jamaluddin; Nicole Prodan; Keith D Richards; Christopher S Walker; Garry Pairaudeau; David M Smith; Roxana-Maria Rujan; Risha Sudra; Christopher A Reynolds; Jason M Booe; Augen A Pioszak; Jack U Flanagan; Michael P Hay; Debbie L Hay
Journal:  ACS Pharmacol Transl Sci       Date:  2020-03-12

8.  Molecular Mechanisms of Class B GPCR Activation: Insights from Adrenomedullin Receptors.

Authors:  Michael L Garelja; Maggie Au; Margaret A Brimble; Joseph J Gingell; Erica R Hendrikse; Annie Lovell; Nicole Prodan; Patrick M Sexton; Andrew Siow; Christopher S Walker; Harriet A Watkins; Geoffrey M Williams; Denise Wootten; Sung H Yang; Paul W R Harris; Debbie L Hay
Journal:  ACS Pharmacol Transl Sci       Date:  2020-02-26

9.  Structure and Dynamics of Adrenomedullin Receptors AM1 and AM2 Reveal Key Mechanisms in the Control of Receptor Phenotype by Receptor Activity-Modifying Proteins.

Authors:  Yi-Lynn Liang; Matthew J Belousoff; Madeleine M Fletcher; Xin Zhang; Maryam Khoshouei; Giuseppe Deganutti; Cassandra Koole; Sebastian G B Furness; Laurence J Miller; Debbie L Hay; Arthur Christopoulos; Christopher A Reynolds; Radostin Danev; Denise Wootten; Patrick M Sexton
Journal:  ACS Pharmacol Transl Sci       Date:  2020-03-20

Review 10.  Amylin structure-function relationships and receptor pharmacology: implications for amylin mimetic drug development.

Authors:  Rebekah L Bower; Debbie L Hay
Journal:  Br J Pharmacol       Date:  2016-05-18       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.